Advertisement

Topics

Sofinnova Partners Raises €106 Million in a First Closing of Its Industrial Biotech Fund

02:30 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Sofinnova Partners, a leading European venture capital firm specialized in life sciences, today announced the first closing of Sofinnova Industrial Biotech I (Sofinnova IB I) at €106 million. The fund, dedicated to renewable ...

Other Sources for this Article

Press contact
SOFINNOVA PARTNERS
Anne REIN, Tel: +33 6 03 35 92 05
anne.rein@strategiesimage.com

NEXT ARTICLE

More From BioPortfolio on "Sofinnova Partners Raises €106 Million in a First Closing of Its Industrial Biotech Fund"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...